Euclid Pharmaceuticals Limited
About Euclid Pharmaceuticals Limited
Data last updated:
Euclid Pharmaceuticals Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 14 November 1990 and has been in existence for over 36 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U17120MH1990PLC058963.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹50 Lakh. It is led by directors including Shantilal Javerchand Jain and Lata Shantilal Jain.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
Court records list 3 cases involving the company, including 3 filed by the company.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Euclid Pharmaceuticals has one previous CIN (Corporate Identification Number): U17120MH1990PTC058963. The current CIN is U17120MH1990PLC058963, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U17120MH1990PLC058963 | Current |
| U17120MH1990PTC058963 | Previous |
Contact details
Euclid Pharmaceuticals Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressFlat No.162 16th Floor Kalpataru Pinnacle Chs.Ltd, Goregaon Mulund Link Road Goregaon(West), Mumbai, Maharashtra, India – 400104
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
To see the full contact details of Euclid Pharmaceuticals Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Euclid Pharmaceuticals Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | |||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | |||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | |||
| Net Profit Margin | |||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Euclid Pharmaceuticals Limited, buy the company report.
Board of directors of Euclid Pharmaceuticals Limited
Euclid Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shantilal Javerchand Jain Also directs: Varsha Commodities Limited, Varsha Mines and Granites Ltd, Amstrin Healthcare Limited and 5 more | Director | 28 Sep 2005 | 21 Years 0 Months | Current |
| Lata Shantilal Jain Also directs: Varsha Commodities Limited, Varsha Mines and Granites Ltd, Varsha Technologies Limited and 4 more | Director | 05 Feb 2016 | 10 Years 8 Months | Current |
| Varsha Shantilal Jain Also directs: Varsha Mines and Granites Ltd, Amstrin Healthcare Limited, Arham Precious Metal Refinery Limited and 5 more | Director | 28 Sep 2005 | 21 Years 0 Months | Current |
Auditor
Euclid Pharmaceuticals Limited is audited by ANILKUMAR MEHTA for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ANILKUMAR MEHTA | FY 2017 | 049485 |
Shareholding
The shareholding of Euclid Pharmaceuticals Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Euclid Pharmaceuticals Limited, buy the company report.
Legal cases
Euclid Pharmaceuticals Limited has 3 court cases on record: 3 filed by Euclid Pharmaceuticals. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 3 | 0 | 0 |
Cases on record (2 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Appeal | Filed by the company | Disposed |
| Bombay High Court | Court case (CSD) | Filed by the company | Disposed |
To see the full case history of Euclid Pharmaceuticals Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Euclid Pharmaceuticals Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Euclid Pharmaceuticals Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Euclid Pharmaceuticals Limited has 4 board changes on record since 2005: 3 appointments and 1 cessation. The latest: Shirish Shantilal Jain ceased to be Director on 09 Feb 2016.
Frequently asked questions
Euclid Pharmaceuticals is an active public limited company based in Mumbai, Maharashtra, India. The company works in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 14 November 1990 (36+ years old) and is registered under CIN U17120MH1990PLC058963.
Euclid Pharmaceuticals has 3 current directors:
- Shantilal Javerchand Jain - Director
- Lata Shantilal Jain - Director
- Varsha Shantilal Jain - Director
The latest financial statements of Euclid Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Euclid Pharmaceuticals is U17120MH1990PLC058963. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Euclid Pharmaceuticals has 3 court cases on record: 3 filed by the company.
Euclid Pharmaceuticals was incorporated on 14 November 1990, making it 36+ years old. It is registered with the Registrar of Companies, Mumbai.
Shirish Shantilal Jain ceased to be Director on 09 Feb 2016. Lata Shantilal Jain was appointed as Director on 05 Feb 2016. Shantilal Javerchand Jain was appointed as Director on 28 Sep 2005. Euclid Pharmaceuticals has 4 board changes on record in total.
The registered office of Euclid Pharmaceuticals is at Flat No.162 16th Floor Kalpataru Pinnacle Chs.Ltd, Goregaon Mulund Link Road GoregaonWest, Mumbai, Maharashtra, India – 400104.
Euclid Pharmaceuticals operates in the chemicals industry, in the medicinal chemical and botanical products segment.
The compliance status of Euclid Pharmaceuticals is compliant as of 03 September 2026. The company is actively filing with the Registrar of Companies.